Other Studies
Rare Cancers ENGOT Registry | MaNGO Study |
STATUS: Recruiting
SPONSOR: Mario Negri Institute for Pharmacological Research (IRFMN)
LEAD GROUP: MaNGO
ENGOT Model: to be defined
TITLE: Rare Cancers in Gynecologic Oncology ENGOT Registry
ClinicalTrials.gov ID: not yet available
Synopsis (click to view Italian version)
Updates (click to view Italian Newsletter)
ENGOT-gyn2 / BOUQUET
STATUS: Recruiting
SPONSOR: Hoffmann-La Roche
LEAD GROUP: GINECO
ENGOT Model: C
TITLE: A phase II, open-label, multicentre, platform study evaluating the efficacy and safety of biomarker driven therapies in patients with persistent or recurrent rare epithelial ovarian tumors
ClinicalTrials.gov ID: NCT04931342
MaNGO Sites (click to see the list)